Clinical Trials

NCT05334329 | ACTIVE_NOT_RECRUITING | PHASE1
6 participants

Genetically Engineered Natural Killer (NK) Cells With or Without Atezolizumab for the Treatment of Non-small Cell Lung Cancer Previously Treated With PD-1 and/or PD-L1 Immune Checkpoint Inhibitors

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-17
Start Date:
2022-07-20
Completion:
2027-06-14
Conditions
  • Advanced Lung Non-Small Cell Carcinoma
  • Metastatic Lung Non-Small Cell Carcinoma
  • Recurrent Lung Non-Small Cell Carcinoma
  • Refractory Lung Non-Small Cell Carcinoma
  • Stage III Lung Cancer AJCC v8
  • Stage IIIA Lung Cancer AJCC v8
  • Stage IIIB Lung Cancer AJCC v8
  • Stage IIIC Lung Cancer AJCC v8
  • Stage IV Lung Cancer AJCC v8
  • Stage IVA Lung Cancer AJCC v8
  • Stage IVB Lung Cancer AJCC v8
Interventions
  • BIOLOGICAL
  • PROCEDURE
  • DRUG
No Results Yet
NCT05141266 | ACTIVE_NOT_RECRUITING | NA
350 participants

Healthy Opioid Prescription Engagement

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-17
Start Date:
2021-11-08
Completion:
2026-06-19
Conditions
  • Opioid Misuse
  • Opioid-Related Disorders
  • Pharmacist-Patient Relations
Interventions
  • BEHAVIORAL
  • OTHER
No Results Yet
NCT05139290 | ENROLLING_BY_INVITATION | NA
40 participants

DECIDE: Dyads and Families

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-17
Start Date:
2022-07-15
Completion:
2027-08-31
Conditions
  • Dementia
  • Alzheimer Disease
  • Caregiver Burden
Interventions
  • BEHAVIORAL
No Results Yet
NCT05132543 | NOT_YET_RECRUITING | NA
38 participants

Neural Basis of Cognition

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-17
Start Date:
2026-09-30
Completion:
2027-09-15
Conditions
  • Epilepsy
Interventions
  • DEVICE
No Results Yet
NCT05078047 | ACTIVE_NOT_RECRUITING | PHASE3
646 participants

Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-17
Start Date:
2022-03-08
Completion:
2029-05-07
Conditions
  • Lung Cancer Metastatic
  • Renal Cell Carcinoma
  • Head and Neck Cancer
  • Triple Negative Breast Cancer
  • Merkel Cell Carcinoma
  • Hepatocellular Carcinoma
  • Melanoma
  • Urothelial Carcinoma
  • Colorectal Carcinoma With Microsatellite Instability
  • Esophageal Squamous Cell Carcinoma
  • Endometrial Carcinoma
  • Cervical Cancer
  • Gastric/Gastro-esophageal Junction/Esophageal Adenocarcinoma
  • Basal Cell Carcinoma
  • Squamous Skin Carcinoma
Interventions
  • DRUG
No Results Yet
NCT05024045 | COMPLETED | PHASE1
27 participants

Study of Oral LOXO-338 in Patients With Advanced Blood Cancers

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-17
Start Date:
2021-09-30
Completion:
2023-06-14
Conditions
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Lymphoma, B-cell Marginal Zone
  • Lymphoma, Non-Hodgkin
  • Multiple Myeloma
  • B-cell Lymphoma
  • Waldenstrom Macroglobulinemia
  • Lymphoma, Mantle-Cell
Interventions
  • DRUG
No Results Yet
NCT05006404 | ACTIVE_NOT_RECRUITING | NA
51 participants

Autus Valve Pivotal Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-17
Start Date:
2024-02-05
Completion:
2026-08-01
Conditions
  • Congenital Heart Disease
Interventions
  • DEVICE
No Results Yet
NCT04970901 | ACTIVE_NOT_RECRUITING | PHASE1
154 participants

A Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination With Other Anti-cancer Agents in Participants With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (LOTIS-7)

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-17
Start Date:
2022-06-17
Completion:
2027-03-31
Conditions
  • B-Cell Non-Hodgkin Lymphoma
  • Relapsed B-Cell Non-Hodgkin Lymphoma
  • Refractory B-Cell Non-Hodgkin Lymphoma
Interventions
  • DRUG
No Results Yet
NCT04915508 | ACTIVE_NOT_RECRUITING | PHASE2
165 participants

Extremely Hypofractionated Intensity Modulated Stereotactic Body Radiotherapy for the Treatment of Prostate Cancer With Rising PSA After Radical Prostatectomy

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-17
Start Date:
2021-06-23
Completion:
2026-12-31
Conditions
  • Prostate Adenocarcinoma
  • Stage IIIB Prostate Cancer American Joint Committee on Cancer (AJCC) v8
  • Stage IIIC Prostate Cancer AJCC v8
  • Stage IV Prostate Cancer AJCC v8
  • Stage IVA Prostate Cancer AJCC v8
  • Stage IVB Prostate Cancer AJCC v8
Interventions
  • DRUG
  • RADIATION
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page